Colum J Smith

2.9k total citations · 1 hit paper
20 papers, 2.1k citations indexed

About

Colum J Smith is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, Colum J Smith has authored 20 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 4 papers in Otorhinolaryngology. Recurrent topics in Colum J Smith's work include Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (12 papers) and Lung Cancer Research Studies (8 papers). Colum J Smith is often cited by papers focused on Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (12 papers) and Lung Cancer Research Studies (8 papers). Colum J Smith collaborates with scholars based in Canada, United States and Australia. Colum J Smith's co-authors include Kathy S. Albain, Valerie W. Rusch, Andrew T. Turrisi, David R. Gandara, Frances A. Shepherd, David H. Johnson, Ruth Swann, Robert C. Miller, Mark R. Green and Gail Darling and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Colum J Smith

19 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

2009 999 citations Kathy S. Albain, Ruth Swann et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Colum J Smith Canada	14	1.5k	869	406	305	219	20	2.1k
Allan Price United Kingdom	18	928 0.6×	830 1.0×	290 0.7×	386 1.3×	125 0.6×	33	1.9k
Sung‐Ja Ahn South Korea	21	619 0.4×	512 0.6×	308 0.8×	94 0.3×	273 1.2×	113	1.5k
Carles Escriu United Kingdom	9	1.5k 1.0×	786 0.9×	424 1.0×	54 0.2×	173 0.8×	29	1.9k
Jean‐Marc Bachaud France	20	837 0.5×	363 0.4×	289 0.7×	48 0.2×	577 2.6×	49	1.7k
Walter L. Eaton United States	15	2.0k 1.3×	1.5k 1.8×	369 0.9×	36 0.1×	140 0.6×	23	2.7k
Katrien Vandecasteele Belgium	19	477 0.3×	290 0.3×	255 0.6×	154 0.5×	211 1.0×	57	1.1k
Josiane Otto France	20	906 0.6×	1.1k 1.3×	204 0.5×	115 0.4×	175 0.8×	59	1.6k
Marie‐Cécile Bozonnat France	7	1.6k 1.0×	710 0.8×	414 1.0×	36 0.1×	159 0.7×	12	1.9k
M. Poudenx France	16	1.1k 0.7×	1.3k 1.5×	174 0.4×	117 0.4×	144 0.7×	41	1.7k
J Maestre Spain	14	1.6k 1.1×	1.1k 1.2×	215 0.5×	105 0.3×	382 1.7×	26	2.5k

Countries citing papers authored by Colum J Smith

Since Specialization

Citations

This map shows the geographic impact of Colum J Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colum J Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colum J Smith more than expected).

Fields of papers citing papers by Colum J Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colum J Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colum J Smith. The network helps show where Colum J Smith may publish in the future.

Co-authorship network of co-authors of Colum J Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Colum J Smith. A scholar is included among the top collaborators of Colum J Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colum J Smith. Colum J Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lawrence, Yaacov Richard, Rebecca Paulus, Corey J. Langer, et al.. (2013). The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: Long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801. Lung Cancer. 80(3). 298–305. 21 indexed citations

Butts, Charles, R. Nevin Murray, Colum J Smith, et al.. (2012). Long-Term Efficacy and Safety of L-BLP25 Vaccine in a Multi-Centre Open-Label Study of Patients with Unresectable Stage III NSCLC. Annals of Oncology. 23. ix395–ix395. 1 indexed citations

Bebb, Gwyn, et al.. (2010). Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy. Cancer Chemotherapy and Pharmacology. 67(4). 837–845. 48 indexed citations

Butts, Charles, R. Nevin Murray, Colum J Smith, et al.. (2010). A Multicenter Open-Label Study to Assess the Safety of a New Formulation of BLP25 Liposome Vaccine in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 11(6). 391–395. 54 indexed citations

Albain, Kathy S., Ruth Swann, Valerie W. Rusch, et al.. (2009). Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. The Lancet. 374(9687). 379–386. 999 indexed citations breakdown →

Murray, Nevin, Charles Butts, Colum J Smith, et al.. (2008). A multicenter, open-label, phase I/II study in patients with unresectable stage III non-small cell lung cancer (NSCLC) treated with L-BLP25: 2-year survival and safety results. Journal of Clinical Oncology. 26(15_suppl). 3047–3047. 1 indexed citations

Bebb, Gwyn, Colum J Smith, Kenneth S. O’Rourke, Anthony Brade, & Igor A. Sherman. (2007). P3-023: Preliminary results of an escalating dose phase I /II clinical trial of the anti EGFR monoclonal antibody nimotuzumab in combination with external radiotherapy in patients diagnosed with stage IIB, III or IV NSCLC unsuitable for radical therapy. Journal of Thoracic Oncology. 2(8). S617–S617. 1 indexed citations

Albain, Kathy S., Ruth Swann, Valerie W. Rusch, et al.. (2005). Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309). Journal of Clinical Oncology. 23(16_suppl). 7014–7014. 165 indexed citations

Movsas, Benjamin, Charles Scott, Corey J. Langer, et al.. (2005). In Reply:. Journal of Clinical Oncology. 23(28). 7233–7235. 1 indexed citations

10.

Choy, Hak, Abdenour Nabid, Baldassarre Stea, et al.. (2005). Phase II Multicenter Study of Induction Chemotherapy Followed by Concurrent Efaproxiral (RSR13) and Thoracic Radiotherapy for Patients With Locally Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 23(25). 5918–5928. 20 indexed citations

11.

Movsas, Benjamin, Charles Scott, Corey J. Langer, et al.. (2005). Randomized Trial of Amifostine in Locally Advanced Non–Small-Cell Lung Cancer Patients Receiving Chemotherapy and Hyperfractionated Radiation: Radiation Therapy Oncology Group Trial 98-01. Journal of Clinical Oncology. 23(10). 2145–2154. 164 indexed citations

12.

Butts, Charles, Nevin Murray, Andrew W. Maksymiuk, et al.. (2005). Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 23(27). 6674–6681. 332 indexed citations

13.

Turrisi, Andrew T., Charles Scott, Valerie W. Rusch, et al.. (2003). Randomized trial of chemoradiotherapy to 61 Gy [no S] versus chemoradiotherapy to 45 Gy followed by surgery [S] using cisplatin etoposide in stage IIIa non-small cell lung cancer (NSCLC): intergroup trial 0139, RTOG (9309). International Journal of Radiation Oncology*Biology*Physics. 57(2). S125–S126. 15 indexed citations

14.

Albain, Kathy S., Charles Scott, Valerie W. Rusch, et al.. (2003). PL-4 Phase III study of concurrent chemotherapy and full course radiotherapy (CT/RT) versus CT/RT induction followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): First outcome analysis of North American Intergroup trial 0139 (RTOG 93-09). Lung Cancer. 41. S4–S4. 57 indexed citations

15.

Werner‐Wasik, Maria, Charles Scott, Benjamin Movsas, et al.. (2003). Amifostine as mucosal protectant in patients with locally advanced non-small cell lung cancer (NSCLC) receiving intensive chemotherapy and thoracic radiotherapy (RT): results of the radiation therapy oncology group (RTOG) 98–01 study. International Journal of Radiation Oncology*Biology*Physics. 57(2). S216–S216. 16 indexed citations

16.

Braun, Ted, et al.. (2003). Oncologists and family physicians. Using a standardized letter to improve communication.. PubMed. 49. 882–6. 20 indexed citations

17.

Bezjak, Andrea, Peter Dixon, Michael Brundage, et al.. (2002). Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15). International Journal of Radiation Oncology*Biology*Physics. 54(3). 719–728. 117 indexed citations

18.

Jha, Naresh, E Rapp, Colum J Smith, et al.. (2001). Concurrent weekly carboplatin and radiotherapy for nasopharyngeal carcinoma: report of a joint phase II study. Radiotherapy and Oncology. 58(2). 131–136. 10 indexed citations

19.

Werner‐Wasik, Maria, Charles Scott, M.L. Graham, et al.. (1999). Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 rtog patients. International Journal of Radiation Oncology*Biology*Physics. 44(2). 327–331. 31 indexed citations

20.

Werner‐Wasik, Maria, Scott Charles, M.L. Graham, et al.. (1997). 2147 Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with hyperfractionated radiotherapy with/without chemotherapy: A multivariate analysis of 682 RTOG patients. International Journal of Radiation Oncology*Biology*Physics. 39(2). 314–314.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact